Short answer
Alpha Teknova, Inc. (TKNO) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $13M (up 21.5% year over year) with net income of −$3M.
Q3 2026 key financials · XBRL
- Revenue
- $13M
- +21.5% YoY · +4.3% QoQ
- Net income
- −$3M
- +18.6% YoY · −10.1% QoQ
- Operating margin
- -25.2%
- Gross margin
- 38.0%
- EPS (diluted)
- −$0.07
- +12.5% YoY · −16.7% QoQ
Source: XBRL data from the Alpha Teknova, Inc. (TKNO) Q3 2026 10-Q on SEC EDGAR. USD.
Alpha Teknova, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $12.7M, up 21.5% YoY from $10.5M
- Gross margin 38.0% vs 30.7% YoY, operating loss $3.2M vs $4.0M
- Clinical Solutions $3.2M, up 85.7% YoY, best-performing category
- Operating cash use $5.1M vs $8.2M YoY, capital expenditures $0.5M
- $42.9M October offering proceeds, inflation, tariffs, interest rates and demand timing headwinds
Risk Factors
- New AI risk: planned use in manufacturing and quality systems creates model-error, data-leakage, and product-quality exposure
- New regulatory risk: California AI laws may require technology changes, higher compliance costs, or trigger penalties
- New market risk: October 2026 offering added 9,200,000 freely tradable shares, increasing potential price pressure
- New compliance risk: emerging-growth-company status ends December 31, 2026, adding reporting obligations
- Financial risk: net losses totaled $11.2 million for the nine months ended September 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Alpha Teknova, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.